Screener
Mesa Laboratories MLAB Clinical Genomics — Gross Profit
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Mesa Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The source filing: Mesa Laboratories’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026808
| Three months ended June 30, 2026 | Sterilization and Disinfection Control | Biopharmaceutical Development | Calibration Solutions | Clinical Genomics | Total |
|---|---|---|---|---|---|
| Amortization in cost of revenue | 121 | 379 | - | 191 | 691 |
| Other cost of revenue (b) | 6,788 | 4,020 | 5,143 | 3,739 | 19,690 |
| Total segment cost of revenue | 7,346 | 4,477 | 5,254 | 4,049 | 21,126 |
| Gross Profit (c) | $17,159 | $7,582 | $8,031 | $6,240 | $39,012 |
| Reconciling items: | |||||
| Operating expense | $31,981 | ||||
| Operating income | 7,031 | ||||
| Non-operating expense, net | 2,678 |
Document
FAQ
- What is Mesa Laboratories's clinical genomics — gross profit?
- Mesa Laboratories (MLAB) reported clinical genomics — gross profit of $6.24M in Q2 2026.
- How has Mesa Laboratories's clinical genomics — gross profit changed year-over-year?
- Mesa Laboratories's clinical genomics — gross profit increased by 15.0% year-over-year, from $5.43M to $6.24M.
- What is the long-term trend for Mesa Laboratories's clinical genomics — gross profit?
- Over 4 years (2022 to 2026), Mesa Laboratories's clinical genomics — gross profit has grown at a 21.5% compound annual growth rate (CAGR), from $11.94M to $26.03M.
- What does clinical genomics — gross profit mean?
- This is the residual profit earned by the Clinical Genomics segment after deducting the direct costs of producing its goods and services from total revenue. It indicates the segment's ability to manage production costs and maintain pricing power in the genomics market.
Ask your AI about Mesa Laboratories's clinical genomics — gross profit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude